MarketScreener Editorial Features Legend Biotech Corporation
Equities
LEGN
US52490G1022
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.72 USD | +1.65% |
|
+0.69% | +34.13% |
| 04:44pm | Legend Biotech Q1 Solid for Carvykti, Focus Shifts to In Vivo Pipeline, RBC Says | MT |
| 01:15pm | RBC Lifts Price Target on Legend Biotech to $64 From $62, Keeps Outperform Rating | MT |
MarketScreener Editorial Features
Search
No results for this search
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition